In the previous studies performed within our team using breast cancer cell lines, we demonstrated that the inhibition of glucose 6-phosphate dehydrogenase (G6PD), the first enzyme of ox-PPP, leads to a decrease in cell proliferation and alterations in the central carbon metabolism [10]. The gene discussed is G6PD; the disease is breast cancer.